MediciNova announces update on phase 2b trial

A board to discuss future MS therapies in early stage (Phase I or II) trials.

MediciNova announces update on phase 2b trial

Postby MSUK » Tue Jun 16, 2015 3:04 am

MediciNova has announced that the ongoing clinical trial of MN-166 (ibudilast) in patients with progressive multiple sclerosis (PMS) has finished the randomisation of 255 patients, exceeding the initial goal of 250 patients........ Read More - http://www.ms-uk.org/MN-166
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2830
Joined: Wed Oct 14, 2009 3:00 pm

Advertisement

Return to Drug Pipeline

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service